Penn Vet | News
Contact
New Bolton Center Kennett Square, PA
Emergencies & Appointments:
610-444-5800
Directions
Ryan Hospital Philadelphia, PA
Emergencies:
215-746-8911
Appointments:
215-746-8387
Directions

Ophthalmology in the News


Penn Vet's Ophthalmology service is often in the news. That's because we have internationally renowned leaders in the field as our faculty and clinicians. Learn more about our team by reading some of the news articles below.


Ophthalmology In the Media


Penn Vet Ophthalmology Stories

ophtho-story2

Identifying a gene for canine night blindness

Creating an effective gene therapy for inherited diseases requires three key steps. First, scientists must identify and characterize the disease. Second, they must find the gene responsible. And finally, they must find a way to correct the impairment.

aguirre-retina-structure-story

Is treatment forever? Success of gene therapy for inherited blindness depends on timing

Nearly two decades ago, a gene therapy restored vision to Lancelot, a Briard dog who was born with a blinding disease. This ushered in a period of hope and progress for the field of gene therapy aimed at curing blindness, which culminated in the 2017 approval of a gene therapy that improved vision in people with Leber congenital amaurosis (LCA), a rare, inherited form of blindness closely related to the condition seen in Lancelot. It represents the first FDA-approved gene therapy for an inherited genetic disease.

ryan-story

Four Faculty Have Been Promoted to Full Professorship at Penn Vet

Four faculty members at Penn Vet have been promoted to full professor in the Department of Clinical Sciences and Advanced Medicine: William A. Beltran, DVM, MSc, PhD; Margret L. Casal, DVM, Dr phil II, PhD; Wilfried Mai, Dr. Méd Vét, MSc, PhD; and Charles H. Vite, DVM, PhD.

blindness-story

Commonalities in Late Stages of Different Inherited Blinding Diseases Suggest Targets for Therapy

Gene therapy holds promise for treating a variety of diseases, including some inherited blinding conditions. But for a gene therapy to be effective, one must know the precise gene responsible for a given individual’s disorder and develop a tailored treatment. For diseases that may be caused by mutations in many different genes, developing individual gene therapy approaches can be prohibitively costly and time-intensive to pursue.